|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,026.00 JPY | +1.53% |
|
+0.36% | -6.37% |
| 07-02 | Japanese Shares Slip as AI Sell-Off Weighs on Investor Sentiment | MT |
| 07-01 | Otsuka Discloses Positive Full Phase 3 Data for Kidney Drug VOYXACT | MT |
Company Valuation: Otsuka Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,040,911 | 787,793 | 1,102,150 | 1,368,537 | 1,225,578 | 1,147,463 | - | - |
| Change | - | -24.32% | 39.9% | 24.17% | -10.45% | -6.37% | - | - |
| Enterprise Value (EV) 1 | 844,195 | 593,018 | 880,762 | 1,147,262 | 980,702 | 889,657 | 864,906 | 824,141 |
| Change | - | -29.75% | 48.52% | 30.26% | -14.52% | -9.28% | -2.78% | -4.71% |
| P/E | 26.1x | 19.7x | 23.2x | 25.6x | 19.1x | 17.9x | 16.7x | 15.4x |
| PBR | 3.48x | 2.47x | 3.21x | 3.69x | 3.11x | 2.69x | 2.5x | 2.28x |
| PEG | - | 82.97x | 1.3x | 2x | 0.9x | -41.4x | 2.35x | 1.72x |
| Capitalization / Revenue | 1.22x | 0.91x | 1.13x | 1.24x | 0.93x | 0.86x | 0.82x | 0.77x |
| EV / Revenue | 0.99x | 0.69x | 0.9x | 1.04x | 0.74x | 0.67x | 0.62x | 0.56x |
| EV / EBITDA | 13.2x | 9.4x | 12.4x | 13.9x | 9.88x | 8.84x | 8.1x | 7.08x |
| EV / EBIT | 15.1x | 10.8x | 14x | 15.4x | 10.9x | 9.78x | 8.89x | 7.77x |
| EV / FCF | 18x | 26.8x | 17.6x | 44.5x | 13.7x | 15.5x | 13x | 11.4x |
| FCF Yield | 5.57% | 3.73% | 5.7% | 2.25% | 7.32% | 6.47% | 7.69% | 8.78% |
| Dividend per Share 2 | 60 | 62.5 | 67.5 | 80 | 90 | 95.83 | 101.3 | 109.4 |
| Rate of return | 2.19% | 3.01% | 2.32% | 2.22% | 2.78% | 3.17% | 3.35% | 3.61% |
| EPS 2 | 105.3 | 105.5 | 125.1 | 141 | 169.6 | 168.8 | 180.8 | 197 |
| Distribution rate | 57% | 59.2% | 53.9% | 56.7% | 53.1% | 56.8% | 56% | 55.5% |
| Net sales 1 | 851,894 | 861,022 | 977,370 | 1,107,668 | 1,322,791 | 1,337,357 | 1,398,402 | 1,481,313 |
| EBITDA 1 | 63,809 | 63,058 | 70,893 | 82,794 | 99,283 | 100,617 | 106,807 | 116,394 |
| EBIT 1 | 55,827 | 54,768 | 62,959 | 74,360 | 89,943 | 90,967 | 97,294 | 106,031 |
| Net income 1 | 39,927 | 40,022 | 47,448 | 53,481 | 64,303 | 64,057 | 68,598 | 74,737 |
| Net Debt 1 | -196,716 | -194,775 | -221,388 | -221,275 | -244,876 | -257,805 | -282,557 | -323,322 |
| Reference price 2 | 2,745.00 | 2,077.50 | 2,906.50 | 3,609.00 | 3,232.00 | 3,026.00 | 3,026.00 | 3,026.00 |
| Nbr of stocks (in thousands) | 379,202 | 379,202 | 379,202 | 379,201 | 379,201 | 379,201 | - | - |
| Announcement Date | 2/1/22 | 2/1/23 | 2/1/24 | 2/3/25 | 2/2/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.92x | 0.67x | 8.84x | 3.17% | 7.01B | |
| 27.51x | 9.37x | 16.61x | 0.99% | 26.38B | |
| 18.44x | 3.58x | 8.99x | 1.48% | 17.79B | |
| 22.6x | 0.69x | 6.62x | 1.59% | 11.1B | |
| 21.42x | 1.47x | 9.83x | 2.34% | 4.25B | |
| 13.53x | 1.18x | 6.53x | 1.5% | 4.24B | |
| 69.6x | 2.66x | 46.64x | 0.68% | 2B | |
| 22.42x | 0.87x | 10.29x | 0.48% | 1.69B | |
| 15.92x | - | - | 2.17% | 1.2B | |
| Average | 25.49x | 2.56x | 14.30x | 1.6% | 8.41B | |
| Weighted average by Cap. | 23.46x | 4.58x | 12.27x | 1.5% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 4768 Stock
- Valuation Otsuka Corporation
Select your edition
All financial news and data tailored to specific country editions
